Catalyst Wire Dossier Catalyst Wire Dossier

Betmiga

mirabegron · Astellas Pharma Europe Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Betmiga, covering 2024-10-31 to 2025-08-27. Get the full timeline:

Most recent: EMA Authorised: Betmiga (Mirabegron) — Astellas Pharma Europe B.V.

See pricing